Evidence map›Paper›PMID 42714680›Full record

ArticleCancer causes & control : CCC2026

Knowledge, attitudes, and self-efficacy toward cancer genetic testing among Black women with and without breast cancer.

Kimberly A Bertrand, Michelle Trevino-Talbot, Maggie Ruderman, Maureen Flynn, Howard J Cabral, Julie R Palmer, Catharine Wang

Abstract read
In one paragraph

Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kimberly A BertrandSlone Epidemiology Center at Boston University, 72 East Concord St, L-7, Boston, MA, 02118, US. kab15@bu.edu.
Michelle Trevino-TalbotBoston Medical Center, Boston, MA, US.
Maggie RudermanBoston University Chobanian & Avedisian School of Medicine, Boston, MA, US.
Maureen FlynnMGH Institute of Health Professions, Boston, MA, US.
Howard J CabralSchool of Public Health, Boston University, Boston, MA, US.
Julie R PalmerSlone Epidemiology Center at Boston University, 72 East Concord St, L-7, Boston, MA, 02118, US.
Catharine WangSchool of Public Health, Boston University, Boston, MA, US.

Funding

A Follow-up Study for Causes of Cancer in Black WomenU01CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Kimberly A. Bertrand, Yvette C Cozier · 2017 to 2026
$24.0M
A Follow-up Study for Causes of Cancer in Black WomenUM1CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 2012 to 2017
$13.7M
Testing scalable communication modalities for returning breast cancer genetic research results to African American womenR01MD014312 · NIMHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PALMER, JULIE R, WANG, CATHARINE · 2020 to 2024
$3.1M
NCI NIH HHS U01 CA164974NCI NIH HHS UM1 CA164974NIH HHS CA164974NIH HHS MD014312NIMHD NIH HHS R01 MD014312
6 · The paper itself

Abstract

objectiveTo assess knowledge and attitudes regarding cancer genetic testing among Black women with and without breast cancer and to identify individual-level predictors of these outcomes.

methodsParticipants were 927 women who completed a questionnaire about personal and family history of cancer; prior hereditary cancer genetic testing; and cancer genetics knowledge, attitudes, and self-efficacy. Linear regression was used to examine predictors of cancer genetics knowledge, attitudes, and self-efficacy.

resultsKnowledge scores did not differ between women who had a history of breast cancer (mean, 12.5/16; SD 2.4) and those who did not (mean, 12.3; SD, 2.4). The majority of women answered most questions correctly; however, incorrect responses were common for questions about inherited cancer etiology (34% answered incorrectly), test limitations (44%), and clinical implications of a variant of uncertain significance (71%). Personal breast cancer history was associated with more favorable attitudes but not self-efficacy. Significant predictors of knowledge, attitudes, or self-efficacy included age, educational attainment, and marital status.

conclusionsOverall knowledge, attitudes, and self-efficacy regarding cancer genetic testing were high among U.S. Black women regardless of prior breast cancer, though educational gaps remain.

Indexed as

Black or African AmericanBreast NeoplasmsGenetic TestingHealth Knowledge, Attitudes, PracticeSelf EfficacyAdultAgedFemaleGenetic Predisposition to DiseaseHumansMiddle AgedSurveys and QuestionnairesBlackCancerGenetic knowledgeGenetic literacyGenetic testingRace

Identifiers

PMID42714680
PMCPMC13558296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.